LXL/RXR and PPARs participate in cellular lipid metabolism as nuclear receptors, and their activation attenuates NASH pathogenesis, implying a protective mechanism against NASH, such as the attenuation of adipose-derived Toll-like receptor 4 activation [44]. This evidence concerns the gene TLR4 and metabolic dysfunction-associated steatohepatitis.